Skip to main content

Want a detailed portfolio tracker?

BioVie (BIVI) P/E (2014 - 2026)

BioVie (BIVI) P/E from May 5, 2014 to Jul 21, 2026. The TTM BioVie (BIVI) P/E is -0.32. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of BioVie (BIVI)

YearP/EChange
2026-0.32+33.66%
2025-0.24-90.59%
2024-2.56-71.30%
2023-8.93-88.76%
2022-79.45-79.57%
2021-388.95-74.02%
2020-1.50K+394.86%
2019-302.51+69.14%
2018-178.86-83.73%
2017-1.10K-82.57%
2016-6.31K+83.17%
2015-3.44K-32.49%
2014-5.10KN/A

Comparison BioVie (BIVI) P/E with competitors

BioVie (BIVI) P/E is -0.32.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.53%
NBYStablecoin Development Corp0.00-101.33%
ENLVEnlivex Ltd0.07-123.21%
FGENFibroGen Inc0.24-174.47%
CHRSCoherus Biosciences Inc0.85-363.25%
FBIOFortress Biotech Inc0.95-394.43%
ORMPOramed Pharmaceuticals Inc1.50-566.30%
AGENAgenus Inc3.01-1033.70%
INVAInnoviva Inc3.15-1078.50%
VXRTVaxart Inc3.55-1201.26%
CRMDCorMedix Inc3.63-1225.68%
CVACCureVac N.V.4.45-1479.21%
GLPGGalapagos NV4.86-1607.41%
SRPTSarepta Therapeutics Inc4.88-1614.61%
ABEOAbeona Therapeutics Inc5.39-1771.41%
ABUSArbutus Biopharma Corp5.60-1835.97%
ZVRAZevra Therapeutics Inc5.89-1926.44%
SPROSpero Therapeutics Inc6.23-2032.29%
CGENCompugen Ltd6.31-2058.82%
RIGLRigel Pharmaceuticals6.87-2231.97%
SLXNSilexion Therapeutics Corp7.30-2363.52%
OMEROmeros Corporation9.26-2972.41%
AUPHAurinia Pharmaceuticals Inc9.58-3073.61%
PLXProtalix BioTherapeutics Inc10.89-3478.80%
ACADAcadia Pharmaceuticals Inc11.73-3738.63%
TBPHTheravance Biopharma Inc12.26-3904.18%
ADMAAdma Biologics Inc12.42-3952.58%
HRMYHarmony Biosciences Holdings Inc13.82-4387.55%
SABSSAB Biotherapeutics Inc14.14-4485.59%
NAGENiagen Bioscience Inc14.82-4697.15%
INCYIncyte Corp15.82-5008.76%
REGNRegeneron Pharmaceuticals Inc15.86-5019.34%
PBYIPuma Biotechnology Inc17.32-5472.00%
CPRXCatalyst Pharmaceuticals Inc17.44-5510.34%
EXELExelixis Inc17.54-5540.97%
TGTXTG Therapeutics Inc18.97-5984.00%
MDXGMimedx Group Inc20.55-6476.18%
XOMAXOMA Royalty Corp22.87-7196.80%
ARGXArgen X SE24.30-7638.37%
CTMXCytomX Therapeutics Inc24.82-7800.67%
XOMAOXOMA Royalty Corp25.34-7963.14%
HALOHalozyme Therapeutics Inc25.62-8049.67%
XOMAPXOMA Royalty Corp25.67-8064.07%
VRTXVertex Pharmaceuticals Inc27.99-8785.27%
RPRXRoyalty Pharma plc - Class A28.69-9000.21%
SLNOSoleno Therapeutics Inc29.02-9101.91%
ASNDAscendis Pharma A/S30.09-9433.94%
LGNDLigand Pharmaceuticals Inc - Class B37.91-11862.08%
APLSApellis Pharmaceuticals Inc39.02-12206.20%
BMRNBiomarin Pharmaceutical Inc42.21-13196.09%
KRYSKrystal Biotech Inc45.34-14167.66%
ONCBeiGene Ltd69.54-21674.70%
PHARPharming Group N.V.75.03-23376.45%
TECHBio-Techne Corp101.96-31732.27%
VCELVericel Corp109.92-34202.75%
ALNYAlnylam Pharmaceuticals Inc117.96-36698.30%
GMABGenmab140.29-43624.77%
TLXTelix Pharmaceuticals Ltd162.15-50407.41%
CORTCorcept Therapeutics Inc212.86-66138.38%